Global Small Nucleic Acid Drug Supply, Demand and Key Producers, 2023-2029
The global Small Nucleic Acid Drug market size is expected to reach $ 15230 million by 2029, rising at a market growth of 20.3% CAGR during the forecast period (2023-2029).
The Small Nucleic Acid Drug Market is driven by the transformative potential of small nucleic acids, including microRNA, aptamers, and small interfering RNA (siRNA), in treating a wide spectrum of diseases, from genetic disorders to cancer and viral infections. These therapies harness the power of small nucleic acids to modulate gene expression, inhibit specific targets, and diagnose diseases, offering a precise and personalized approach to treatment. As genomics and RNA-based research advance, and precision medicine gains prominence, the demand for small nucleic acid drugs continues to surge. Innovations in nucleic acid design, delivery systems, and gene-editing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to overcome hurdles related to safe and efficient drug delivery, minimize off-target effects, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Addressing delivery challenges, optimizing pharmacokinetics, and managing development costs are ongoing hurdles. Additionally, the market faces competition from traditional therapeutic approaches, necessitating continuous research and development efforts to unlock the full therapeutic potential of small nucleic acid drugs. Striking a balance between providing safe, effective, and accessible small nucleic acid therapies while addressing scientific and regulatory challenges is paramount for the continued growth of the Small Nucleic Acid Drug Market.
Small nucleic acid drugs, such as siRNA, ASO, miRNA, Aptamer, etc., function based on the RNAi process and offer various advantages, including unlimited target druggability, high specificity, long half-life, faster and more efficient design, development and production process.
This report studies the global Small Nucleic Acid Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Small Nucleic Acid Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Small Nucleic Acid Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Small Nucleic Acid Drug total market, 2018-2029, (USD Million)
Global Small Nucleic Acid Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Small Nucleic Acid Drug total market, key domestic companies and share, (USD Million)
Global Small Nucleic Acid Drug revenue by player and market share 2018-2023, (USD Million)
Global Small Nucleic Acid Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Small Nucleic Acid Drug total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Small Nucleic Acid Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals and CureVac, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Small Nucleic Acid Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Small Nucleic Acid Drug Market, By Region:
1. How big is the global Small Nucleic Acid Drug market?
2. What is the demand of the global Small Nucleic Acid Drug market?
3. What is the year over year growth of the global Small Nucleic Acid Drug market?
4. What is the total value of the global Small Nucleic Acid Drug market?
5. Who are the major players in the global Small Nucleic Acid Drug market?
The Small Nucleic Acid Drug Market is driven by the transformative potential of small nucleic acids, including microRNA, aptamers, and small interfering RNA (siRNA), in treating a wide spectrum of diseases, from genetic disorders to cancer and viral infections. These therapies harness the power of small nucleic acids to modulate gene expression, inhibit specific targets, and diagnose diseases, offering a precise and personalized approach to treatment. As genomics and RNA-based research advance, and precision medicine gains prominence, the demand for small nucleic acid drugs continues to surge. Innovations in nucleic acid design, delivery systems, and gene-editing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to overcome hurdles related to safe and efficient drug delivery, minimize off-target effects, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Addressing delivery challenges, optimizing pharmacokinetics, and managing development costs are ongoing hurdles. Additionally, the market faces competition from traditional therapeutic approaches, necessitating continuous research and development efforts to unlock the full therapeutic potential of small nucleic acid drugs. Striking a balance between providing safe, effective, and accessible small nucleic acid therapies while addressing scientific and regulatory challenges is paramount for the continued growth of the Small Nucleic Acid Drug Market.
Small nucleic acid drugs, such as siRNA, ASO, miRNA, Aptamer, etc., function based on the RNAi process and offer various advantages, including unlimited target druggability, high specificity, long half-life, faster and more efficient design, development and production process.
This report studies the global Small Nucleic Acid Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Small Nucleic Acid Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Small Nucleic Acid Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Small Nucleic Acid Drug total market, 2018-2029, (USD Million)
Global Small Nucleic Acid Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Small Nucleic Acid Drug total market, key domestic companies and share, (USD Million)
Global Small Nucleic Acid Drug revenue by player and market share 2018-2023, (USD Million)
Global Small Nucleic Acid Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Small Nucleic Acid Drug total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Small Nucleic Acid Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals and CureVac, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Small Nucleic Acid Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Small Nucleic Acid Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antisense Oligonucleotides (ASO)
- siRNA
- Other
- Neuromuscular Diseases
- hATTR
- Other
- Sarepta Therapeutics
- Ionis Pharmaceuticals
- Alnylam
- Biogen
- Nippon Shinyaku
- Sobi
- Novartis
- Jazz Pharmaceuticals
- CureVac
- Regulus Therapeutics
- ProQR
- Secarna
- MiNA Therapeutics
- Sylentis
- Arrowhead
- Silence Therapeutics
- Dicerna
1. How big is the global Small Nucleic Acid Drug market?
2. What is the demand of the global Small Nucleic Acid Drug market?
3. What is the year over year growth of the global Small Nucleic Acid Drug market?
4. What is the total value of the global Small Nucleic Acid Drug market?
5. Who are the major players in the global Small Nucleic Acid Drug market?
1 SUPPLY SUMMARY
1.1 Small Nucleic Acid Drug Introduction
1.2 World Small Nucleic Acid Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Small Nucleic Acid Drug Total Market by Region (by Headquarter Location)
1.3.1 World Small Nucleic Acid Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Small Nucleic Acid Drug Market Size (2018-2029)
1.3.3 China Small Nucleic Acid Drug Market Size (2018-2029)
1.3.4 Europe Small Nucleic Acid Drug Market Size (2018-2029)
1.3.5 Japan Small Nucleic Acid Drug Market Size (2018-2029)
1.3.6 South Korea Small Nucleic Acid Drug Market Size (2018-2029)
1.3.7 ASEAN Small Nucleic Acid Drug Market Size (2018-2029)
1.3.8 India Small Nucleic Acid Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Small Nucleic Acid Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Small Nucleic Acid Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Small Nucleic Acid Drug Consumption Value (2018-2029)
2.2 World Small Nucleic Acid Drug Consumption Value by Region
2.2.1 World Small Nucleic Acid Drug Consumption Value by Region (2018-2023)
2.2.2 World Small Nucleic Acid Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Small Nucleic Acid Drug Consumption Value (2018-2029)
2.4 China Small Nucleic Acid Drug Consumption Value (2018-2029)
2.5 Europe Small Nucleic Acid Drug Consumption Value (2018-2029)
2.6 Japan Small Nucleic Acid Drug Consumption Value (2018-2029)
2.7 South Korea Small Nucleic Acid Drug Consumption Value (2018-2029)
2.8 ASEAN Small Nucleic Acid Drug Consumption Value (2018-2029)
2.9 India Small Nucleic Acid Drug Consumption Value (2018-2029)
3 WORLD SMALL NUCLEIC ACID DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Small Nucleic Acid Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Small Nucleic Acid Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Small Nucleic Acid Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Small Nucleic Acid Drug in 2022
3.3 Small Nucleic Acid Drug Company Evaluation Quadrant
3.4 Small Nucleic Acid Drug Market: Overall Company Footprint Analysis
3.4.1 Small Nucleic Acid Drug Market: Region Footprint
3.4.2 Small Nucleic Acid Drug Market: Company Product Type Footprint
3.4.3 Small Nucleic Acid Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Small Nucleic Acid Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Small Nucleic Acid Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Small Nucleic Acid Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Small Nucleic Acid Drug Consumption Value Comparison
4.2.1 United States VS China: Small Nucleic Acid Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Small Nucleic Acid Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Small Nucleic Acid Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Small Nucleic Acid Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Small Nucleic Acid Drug Revenue, (2018-2023)
4.4 China Based Companies Small Nucleic Acid Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Small Nucleic Acid Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Small Nucleic Acid Drug Revenue, (2018-2023)
4.5 Rest of World Based Small Nucleic Acid Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Small Nucleic Acid Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Small Nucleic Acid Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Small Nucleic Acid Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antisense Oligonucleotides (ASO)
5.2.2 siRNA
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Small Nucleic Acid Drug Market Size by Type (2018-2023)
5.3.2 World Small Nucleic Acid Drug Market Size by Type (2024-2029)
5.3.3 World Small Nucleic Acid Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Small Nucleic Acid Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Neuromuscular Diseases
6.2.2 hATTR
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Small Nucleic Acid Drug Market Size by Application (2018-2023)
6.3.2 World Small Nucleic Acid Drug Market Size by Application (2024-2029)
6.3.3 World Small Nucleic Acid Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sarepta Therapeutics
7.1.1 Sarepta Therapeutics Details
7.1.2 Sarepta Therapeutics Major Business
7.1.3 Sarepta Therapeutics Small Nucleic Acid Drug Product and Services
7.1.4 Sarepta Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sarepta Therapeutics Recent Developments/Updates
7.1.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.2 Ionis Pharmaceuticals
7.2.1 Ionis Pharmaceuticals Details
7.2.2 Ionis Pharmaceuticals Major Business
7.2.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Product and Services
7.2.4 Ionis Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Ionis Pharmaceuticals Recent Developments/Updates
7.2.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Alnylam
7.3.1 Alnylam Details
7.3.2 Alnylam Major Business
7.3.3 Alnylam Small Nucleic Acid Drug Product and Services
7.3.4 Alnylam Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Alnylam Recent Developments/Updates
7.3.6 Alnylam Competitive Strengths & Weaknesses
7.4 Biogen
7.4.1 Biogen Details
7.4.2 Biogen Major Business
7.4.3 Biogen Small Nucleic Acid Drug Product and Services
7.4.4 Biogen Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Biogen Recent Developments/Updates
7.4.6 Biogen Competitive Strengths & Weaknesses
7.5 Nippon Shinyaku
7.5.1 Nippon Shinyaku Details
7.5.2 Nippon Shinyaku Major Business
7.5.3 Nippon Shinyaku Small Nucleic Acid Drug Product and Services
7.5.4 Nippon Shinyaku Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Nippon Shinyaku Recent Developments/Updates
7.5.6 Nippon Shinyaku Competitive Strengths & Weaknesses
7.6 Sobi
7.6.1 Sobi Details
7.6.2 Sobi Major Business
7.6.3 Sobi Small Nucleic Acid Drug Product and Services
7.6.4 Sobi Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Sobi Recent Developments/Updates
7.6.6 Sobi Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis Small Nucleic Acid Drug Product and Services
7.7.4 Novartis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
7.8 Jazz Pharmaceuticals
7.8.1 Jazz Pharmaceuticals Details
7.8.2 Jazz Pharmaceuticals Major Business
7.8.3 Jazz Pharmaceuticals Small Nucleic Acid Drug Product and Services
7.8.4 Jazz Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Jazz Pharmaceuticals Recent Developments/Updates
7.8.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
7.9 CureVac
7.9.1 CureVac Details
7.9.2 CureVac Major Business
7.9.3 CureVac Small Nucleic Acid Drug Product and Services
7.9.4 CureVac Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 CureVac Recent Developments/Updates
7.9.6 CureVac Competitive Strengths & Weaknesses
7.10 Regulus Therapeutics
7.10.1 Regulus Therapeutics Details
7.10.2 Regulus Therapeutics Major Business
7.10.3 Regulus Therapeutics Small Nucleic Acid Drug Product and Services
7.10.4 Regulus Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Regulus Therapeutics Recent Developments/Updates
7.10.6 Regulus Therapeutics Competitive Strengths & Weaknesses
7.11 ProQR
7.11.1 ProQR Details
7.11.2 ProQR Major Business
7.11.3 ProQR Small Nucleic Acid Drug Product and Services
7.11.4 ProQR Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 ProQR Recent Developments/Updates
7.11.6 ProQR Competitive Strengths & Weaknesses
7.12 Secarna
7.12.1 Secarna Details
7.12.2 Secarna Major Business
7.12.3 Secarna Small Nucleic Acid Drug Product and Services
7.12.4 Secarna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Secarna Recent Developments/Updates
7.12.6 Secarna Competitive Strengths & Weaknesses
7.13 MiNA Therapeutics
7.13.1 MiNA Therapeutics Details
7.13.2 MiNA Therapeutics Major Business
7.13.3 MiNA Therapeutics Small Nucleic Acid Drug Product and Services
7.13.4 MiNA Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 MiNA Therapeutics Recent Developments/Updates
7.13.6 MiNA Therapeutics Competitive Strengths & Weaknesses
7.14 Sylentis
7.14.1 Sylentis Details
7.14.2 Sylentis Major Business
7.14.3 Sylentis Small Nucleic Acid Drug Product and Services
7.14.4 Sylentis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Sylentis Recent Developments/Updates
7.14.6 Sylentis Competitive Strengths & Weaknesses
7.15 Arrowhead
7.15.1 Arrowhead Details
7.15.2 Arrowhead Major Business
7.15.3 Arrowhead Small Nucleic Acid Drug Product and Services
7.15.4 Arrowhead Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Arrowhead Recent Developments/Updates
7.15.6 Arrowhead Competitive Strengths & Weaknesses
7.16 Silence Therapeutics
7.16.1 Silence Therapeutics Details
7.16.2 Silence Therapeutics Major Business
7.16.3 Silence Therapeutics Small Nucleic Acid Drug Product and Services
7.16.4 Silence Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Silence Therapeutics Recent Developments/Updates
7.16.6 Silence Therapeutics Competitive Strengths & Weaknesses
7.17 Dicerna
7.17.1 Dicerna Details
7.17.2 Dicerna Major Business
7.17.3 Dicerna Small Nucleic Acid Drug Product and Services
7.17.4 Dicerna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Dicerna Recent Developments/Updates
7.17.6 Dicerna Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Small Nucleic Acid Drug Industry Chain
8.2 Small Nucleic Acid Drug Upstream Analysis
8.3 Small Nucleic Acid Drug Midstream Analysis
8.4 Small Nucleic Acid Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Small Nucleic Acid Drug Introduction
1.2 World Small Nucleic Acid Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Small Nucleic Acid Drug Total Market by Region (by Headquarter Location)
1.3.1 World Small Nucleic Acid Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Small Nucleic Acid Drug Market Size (2018-2029)
1.3.3 China Small Nucleic Acid Drug Market Size (2018-2029)
1.3.4 Europe Small Nucleic Acid Drug Market Size (2018-2029)
1.3.5 Japan Small Nucleic Acid Drug Market Size (2018-2029)
1.3.6 South Korea Small Nucleic Acid Drug Market Size (2018-2029)
1.3.7 ASEAN Small Nucleic Acid Drug Market Size (2018-2029)
1.3.8 India Small Nucleic Acid Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Small Nucleic Acid Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Small Nucleic Acid Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Small Nucleic Acid Drug Consumption Value (2018-2029)
2.2 World Small Nucleic Acid Drug Consumption Value by Region
2.2.1 World Small Nucleic Acid Drug Consumption Value by Region (2018-2023)
2.2.2 World Small Nucleic Acid Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Small Nucleic Acid Drug Consumption Value (2018-2029)
2.4 China Small Nucleic Acid Drug Consumption Value (2018-2029)
2.5 Europe Small Nucleic Acid Drug Consumption Value (2018-2029)
2.6 Japan Small Nucleic Acid Drug Consumption Value (2018-2029)
2.7 South Korea Small Nucleic Acid Drug Consumption Value (2018-2029)
2.8 ASEAN Small Nucleic Acid Drug Consumption Value (2018-2029)
2.9 India Small Nucleic Acid Drug Consumption Value (2018-2029)
3 WORLD SMALL NUCLEIC ACID DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Small Nucleic Acid Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Small Nucleic Acid Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Small Nucleic Acid Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Small Nucleic Acid Drug in 2022
3.3 Small Nucleic Acid Drug Company Evaluation Quadrant
3.4 Small Nucleic Acid Drug Market: Overall Company Footprint Analysis
3.4.1 Small Nucleic Acid Drug Market: Region Footprint
3.4.2 Small Nucleic Acid Drug Market: Company Product Type Footprint
3.4.3 Small Nucleic Acid Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Small Nucleic Acid Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Small Nucleic Acid Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Small Nucleic Acid Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Small Nucleic Acid Drug Consumption Value Comparison
4.2.1 United States VS China: Small Nucleic Acid Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Small Nucleic Acid Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Small Nucleic Acid Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Small Nucleic Acid Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Small Nucleic Acid Drug Revenue, (2018-2023)
4.4 China Based Companies Small Nucleic Acid Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Small Nucleic Acid Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Small Nucleic Acid Drug Revenue, (2018-2023)
4.5 Rest of World Based Small Nucleic Acid Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Small Nucleic Acid Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Small Nucleic Acid Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Small Nucleic Acid Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antisense Oligonucleotides (ASO)
5.2.2 siRNA
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Small Nucleic Acid Drug Market Size by Type (2018-2023)
5.3.2 World Small Nucleic Acid Drug Market Size by Type (2024-2029)
5.3.3 World Small Nucleic Acid Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Small Nucleic Acid Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Neuromuscular Diseases
6.2.2 hATTR
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Small Nucleic Acid Drug Market Size by Application (2018-2023)
6.3.2 World Small Nucleic Acid Drug Market Size by Application (2024-2029)
6.3.3 World Small Nucleic Acid Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sarepta Therapeutics
7.1.1 Sarepta Therapeutics Details
7.1.2 Sarepta Therapeutics Major Business
7.1.3 Sarepta Therapeutics Small Nucleic Acid Drug Product and Services
7.1.4 Sarepta Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sarepta Therapeutics Recent Developments/Updates
7.1.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.2 Ionis Pharmaceuticals
7.2.1 Ionis Pharmaceuticals Details
7.2.2 Ionis Pharmaceuticals Major Business
7.2.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Product and Services
7.2.4 Ionis Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Ionis Pharmaceuticals Recent Developments/Updates
7.2.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Alnylam
7.3.1 Alnylam Details
7.3.2 Alnylam Major Business
7.3.3 Alnylam Small Nucleic Acid Drug Product and Services
7.3.4 Alnylam Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Alnylam Recent Developments/Updates
7.3.6 Alnylam Competitive Strengths & Weaknesses
7.4 Biogen
7.4.1 Biogen Details
7.4.2 Biogen Major Business
7.4.3 Biogen Small Nucleic Acid Drug Product and Services
7.4.4 Biogen Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Biogen Recent Developments/Updates
7.4.6 Biogen Competitive Strengths & Weaknesses
7.5 Nippon Shinyaku
7.5.1 Nippon Shinyaku Details
7.5.2 Nippon Shinyaku Major Business
7.5.3 Nippon Shinyaku Small Nucleic Acid Drug Product and Services
7.5.4 Nippon Shinyaku Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Nippon Shinyaku Recent Developments/Updates
7.5.6 Nippon Shinyaku Competitive Strengths & Weaknesses
7.6 Sobi
7.6.1 Sobi Details
7.6.2 Sobi Major Business
7.6.3 Sobi Small Nucleic Acid Drug Product and Services
7.6.4 Sobi Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Sobi Recent Developments/Updates
7.6.6 Sobi Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis Small Nucleic Acid Drug Product and Services
7.7.4 Novartis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
7.8 Jazz Pharmaceuticals
7.8.1 Jazz Pharmaceuticals Details
7.8.2 Jazz Pharmaceuticals Major Business
7.8.3 Jazz Pharmaceuticals Small Nucleic Acid Drug Product and Services
7.8.4 Jazz Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Jazz Pharmaceuticals Recent Developments/Updates
7.8.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
7.9 CureVac
7.9.1 CureVac Details
7.9.2 CureVac Major Business
7.9.3 CureVac Small Nucleic Acid Drug Product and Services
7.9.4 CureVac Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 CureVac Recent Developments/Updates
7.9.6 CureVac Competitive Strengths & Weaknesses
7.10 Regulus Therapeutics
7.10.1 Regulus Therapeutics Details
7.10.2 Regulus Therapeutics Major Business
7.10.3 Regulus Therapeutics Small Nucleic Acid Drug Product and Services
7.10.4 Regulus Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Regulus Therapeutics Recent Developments/Updates
7.10.6 Regulus Therapeutics Competitive Strengths & Weaknesses
7.11 ProQR
7.11.1 ProQR Details
7.11.2 ProQR Major Business
7.11.3 ProQR Small Nucleic Acid Drug Product and Services
7.11.4 ProQR Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 ProQR Recent Developments/Updates
7.11.6 ProQR Competitive Strengths & Weaknesses
7.12 Secarna
7.12.1 Secarna Details
7.12.2 Secarna Major Business
7.12.3 Secarna Small Nucleic Acid Drug Product and Services
7.12.4 Secarna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Secarna Recent Developments/Updates
7.12.6 Secarna Competitive Strengths & Weaknesses
7.13 MiNA Therapeutics
7.13.1 MiNA Therapeutics Details
7.13.2 MiNA Therapeutics Major Business
7.13.3 MiNA Therapeutics Small Nucleic Acid Drug Product and Services
7.13.4 MiNA Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 MiNA Therapeutics Recent Developments/Updates
7.13.6 MiNA Therapeutics Competitive Strengths & Weaknesses
7.14 Sylentis
7.14.1 Sylentis Details
7.14.2 Sylentis Major Business
7.14.3 Sylentis Small Nucleic Acid Drug Product and Services
7.14.4 Sylentis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Sylentis Recent Developments/Updates
7.14.6 Sylentis Competitive Strengths & Weaknesses
7.15 Arrowhead
7.15.1 Arrowhead Details
7.15.2 Arrowhead Major Business
7.15.3 Arrowhead Small Nucleic Acid Drug Product and Services
7.15.4 Arrowhead Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Arrowhead Recent Developments/Updates
7.15.6 Arrowhead Competitive Strengths & Weaknesses
7.16 Silence Therapeutics
7.16.1 Silence Therapeutics Details
7.16.2 Silence Therapeutics Major Business
7.16.3 Silence Therapeutics Small Nucleic Acid Drug Product and Services
7.16.4 Silence Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Silence Therapeutics Recent Developments/Updates
7.16.6 Silence Therapeutics Competitive Strengths & Weaknesses
7.17 Dicerna
7.17.1 Dicerna Details
7.17.2 Dicerna Major Business
7.17.3 Dicerna Small Nucleic Acid Drug Product and Services
7.17.4 Dicerna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Dicerna Recent Developments/Updates
7.17.6 Dicerna Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Small Nucleic Acid Drug Industry Chain
8.2 Small Nucleic Acid Drug Upstream Analysis
8.3 Small Nucleic Acid Drug Midstream Analysis
8.4 Small Nucleic Acid Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Small Nucleic Acid Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Small Nucleic Acid Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Small Nucleic Acid Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Small Nucleic Acid Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Small Nucleic Acid Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Small Nucleic Acid Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Small Nucleic Acid Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Small Nucleic Acid Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Small Nucleic Acid Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Small Nucleic Acid Drug Players in 2022
Table 12. World Small Nucleic Acid Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Small Nucleic Acid Drug Company Evaluation Quadrant
Table 14. Head Office of Key Small Nucleic Acid Drug Player
Table 15. Small Nucleic Acid Drug Market: Company Product Type Footprint
Table 16. Small Nucleic Acid Drug Market: Company Product Application Footprint
Table 17. Small Nucleic Acid Drug Mergers & Acquisitions Activity
Table 18. United States VS China Small Nucleic Acid Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Small Nucleic Acid Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Small Nucleic Acid Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Small Nucleic Acid Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Small Nucleic Acid Drug Revenue Market Share (2018-2023)
Table 23. China Based Small Nucleic Acid Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Small Nucleic Acid Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Small Nucleic Acid Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Small Nucleic Acid Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Small Nucleic Acid Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Small Nucleic Acid Drug Revenue Market Share (2018-2023)
Table 29. World Small Nucleic Acid Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Small Nucleic Acid Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Small Nucleic Acid Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Small Nucleic Acid Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Small Nucleic Acid Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Small Nucleic Acid Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 36. Sarepta Therapeutics Major Business
Table 37. Sarepta Therapeutics Small Nucleic Acid Drug Product and Services
Table 38. Sarepta Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sarepta Therapeutics Recent Developments/Updates
Table 40. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 41. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
Table 42. Ionis Pharmaceuticals Major Business
Table 43. Ionis Pharmaceuticals Small Nucleic Acid Drug Product and Services
Table 44. Ionis Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Ionis Pharmaceuticals Recent Developments/Updates
Table 46. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Alnylam Basic Information, Area Served and Competitors
Table 48. Alnylam Major Business
Table 49. Alnylam Small Nucleic Acid Drug Product and Services
Table 50. Alnylam Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Alnylam Recent Developments/Updates
Table 52. Alnylam Competitive Strengths & Weaknesses
Table 53. Biogen Basic Information, Area Served and Competitors
Table 54. Biogen Major Business
Table 55. Biogen Small Nucleic Acid Drug Product and Services
Table 56. Biogen Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Biogen Recent Developments/Updates
Table 58. Biogen Competitive Strengths & Weaknesses
Table 59. Nippon Shinyaku Basic Information, Area Served and Competitors
Table 60. Nippon Shinyaku Major Business
Table 61. Nippon Shinyaku Small Nucleic Acid Drug Product and Services
Table 62. Nippon Shinyaku Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Nippon Shinyaku Recent Developments/Updates
Table 64. Nippon Shinyaku Competitive Strengths & Weaknesses
Table 65. Sobi Basic Information, Area Served and Competitors
Table 66. Sobi Major Business
Table 67. Sobi Small Nucleic Acid Drug Product and Services
Table 68. Sobi Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Sobi Recent Developments/Updates
Table 70. Sobi Competitive Strengths & Weaknesses
Table 71. Novartis Basic Information, Area Served and Competitors
Table 72. Novartis Major Business
Table 73. Novartis Small Nucleic Acid Drug Product and Services
Table 74. Novartis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novartis Recent Developments/Updates
Table 76. Novartis Competitive Strengths & Weaknesses
Table 77. Jazz Pharmaceuticals Basic Information, Area Served and Competitors
Table 78. Jazz Pharmaceuticals Major Business
Table 79. Jazz Pharmaceuticals Small Nucleic Acid Drug Product and Services
Table 80. Jazz Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Jazz Pharmaceuticals Recent Developments/Updates
Table 82. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. CureVac Basic Information, Area Served and Competitors
Table 84. CureVac Major Business
Table 85. CureVac Small Nucleic Acid Drug Product and Services
Table 86. CureVac Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. CureVac Recent Developments/Updates
Table 88. CureVac Competitive Strengths & Weaknesses
Table 89. Regulus Therapeutics Basic Information, Area Served and Competitors
Table 90. Regulus Therapeutics Major Business
Table 91. Regulus Therapeutics Small Nucleic Acid Drug Product and Services
Table 92. Regulus Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Regulus Therapeutics Recent Developments/Updates
Table 94. Regulus Therapeutics Competitive Strengths & Weaknesses
Table 95. ProQR Basic Information, Area Served and Competitors
Table 96. ProQR Major Business
Table 97. ProQR Small Nucleic Acid Drug Product and Services
Table 98. ProQR Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. ProQR Recent Developments/Updates
Table 100. ProQR Competitive Strengths & Weaknesses
Table 101. Secarna Basic Information, Area Served and Competitors
Table 102. Secarna Major Business
Table 103. Secarna Small Nucleic Acid Drug Product and Services
Table 104. Secarna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Secarna Recent Developments/Updates
Table 106. Secarna Competitive Strengths & Weaknesses
Table 107. MiNA Therapeutics Basic Information, Area Served and Competitors
Table 108. MiNA Therapeutics Major Business
Table 109. MiNA Therapeutics Small Nucleic Acid Drug Product and Services
Table 110. MiNA Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. MiNA Therapeutics Recent Developments/Updates
Table 112. MiNA Therapeutics Competitive Strengths & Weaknesses
Table 113. Sylentis Basic Information, Area Served and Competitors
Table 114. Sylentis Major Business
Table 115. Sylentis Small Nucleic Acid Drug Product and Services
Table 116. Sylentis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Sylentis Recent Developments/Updates
Table 118. Sylentis Competitive Strengths & Weaknesses
Table 119. Arrowhead Basic Information, Area Served and Competitors
Table 120. Arrowhead Major Business
Table 121. Arrowhead Small Nucleic Acid Drug Product and Services
Table 122. Arrowhead Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Arrowhead Recent Developments/Updates
Table 124. Arrowhead Competitive Strengths & Weaknesses
Table 125. Silence Therapeutics Basic Information, Area Served and Competitors
Table 126. Silence Therapeutics Major Business
Table 127. Silence Therapeutics Small Nucleic Acid Drug Product and Services
Table 128. Silence Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Silence Therapeutics Recent Developments/Updates
Table 130. Dicerna Basic Information, Area Served and Competitors
Table 131. Dicerna Major Business
Table 132. Dicerna Small Nucleic Acid Drug Product and Services
Table 133. Dicerna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Small Nucleic Acid Drug Upstream (Raw Materials)
Table 135. Small Nucleic Acid Drug Typical Customers
LIST OF FIGURE
Figure 1. Small Nucleic Acid Drug Picture
Figure 2. World Small Nucleic Acid Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Small Nucleic Acid Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Small Nucleic Acid Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Small Nucleic Acid Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 13. Small Nucleic Acid Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Small Nucleic Acid Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Small Nucleic Acid Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Small Nucleic Acid Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Small Nucleic Acid Drug Markets in 2022
Figure 27. United States VS China: Small Nucleic Acid Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Small Nucleic Acid Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Small Nucleic Acid Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Small Nucleic Acid Drug Market Size Market Share by Type in 2022
Figure 31. Antisense Oligonucleotides (ASO)
Figure 32. siRNA
Figure 33. Other
Figure 34. World Small Nucleic Acid Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Small Nucleic Acid Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Small Nucleic Acid Drug Market Size Market Share by Application in 2022
Figure 37. Neuromuscular Diseases
Figure 38. hATTR
Figure 39. Other
Figure 40. Small Nucleic Acid Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Small Nucleic Acid Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Small Nucleic Acid Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Small Nucleic Acid Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Small Nucleic Acid Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Small Nucleic Acid Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Small Nucleic Acid Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Small Nucleic Acid Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Small Nucleic Acid Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Small Nucleic Acid Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Small Nucleic Acid Drug Players in 2022
Table 12. World Small Nucleic Acid Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Small Nucleic Acid Drug Company Evaluation Quadrant
Table 14. Head Office of Key Small Nucleic Acid Drug Player
Table 15. Small Nucleic Acid Drug Market: Company Product Type Footprint
Table 16. Small Nucleic Acid Drug Market: Company Product Application Footprint
Table 17. Small Nucleic Acid Drug Mergers & Acquisitions Activity
Table 18. United States VS China Small Nucleic Acid Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Small Nucleic Acid Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Small Nucleic Acid Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Small Nucleic Acid Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Small Nucleic Acid Drug Revenue Market Share (2018-2023)
Table 23. China Based Small Nucleic Acid Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Small Nucleic Acid Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Small Nucleic Acid Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Small Nucleic Acid Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Small Nucleic Acid Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Small Nucleic Acid Drug Revenue Market Share (2018-2023)
Table 29. World Small Nucleic Acid Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Small Nucleic Acid Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Small Nucleic Acid Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Small Nucleic Acid Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Small Nucleic Acid Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Small Nucleic Acid Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 36. Sarepta Therapeutics Major Business
Table 37. Sarepta Therapeutics Small Nucleic Acid Drug Product and Services
Table 38. Sarepta Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sarepta Therapeutics Recent Developments/Updates
Table 40. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 41. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
Table 42. Ionis Pharmaceuticals Major Business
Table 43. Ionis Pharmaceuticals Small Nucleic Acid Drug Product and Services
Table 44. Ionis Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Ionis Pharmaceuticals Recent Developments/Updates
Table 46. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Alnylam Basic Information, Area Served and Competitors
Table 48. Alnylam Major Business
Table 49. Alnylam Small Nucleic Acid Drug Product and Services
Table 50. Alnylam Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Alnylam Recent Developments/Updates
Table 52. Alnylam Competitive Strengths & Weaknesses
Table 53. Biogen Basic Information, Area Served and Competitors
Table 54. Biogen Major Business
Table 55. Biogen Small Nucleic Acid Drug Product and Services
Table 56. Biogen Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Biogen Recent Developments/Updates
Table 58. Biogen Competitive Strengths & Weaknesses
Table 59. Nippon Shinyaku Basic Information, Area Served and Competitors
Table 60. Nippon Shinyaku Major Business
Table 61. Nippon Shinyaku Small Nucleic Acid Drug Product and Services
Table 62. Nippon Shinyaku Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Nippon Shinyaku Recent Developments/Updates
Table 64. Nippon Shinyaku Competitive Strengths & Weaknesses
Table 65. Sobi Basic Information, Area Served and Competitors
Table 66. Sobi Major Business
Table 67. Sobi Small Nucleic Acid Drug Product and Services
Table 68. Sobi Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Sobi Recent Developments/Updates
Table 70. Sobi Competitive Strengths & Weaknesses
Table 71. Novartis Basic Information, Area Served and Competitors
Table 72. Novartis Major Business
Table 73. Novartis Small Nucleic Acid Drug Product and Services
Table 74. Novartis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novartis Recent Developments/Updates
Table 76. Novartis Competitive Strengths & Weaknesses
Table 77. Jazz Pharmaceuticals Basic Information, Area Served and Competitors
Table 78. Jazz Pharmaceuticals Major Business
Table 79. Jazz Pharmaceuticals Small Nucleic Acid Drug Product and Services
Table 80. Jazz Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Jazz Pharmaceuticals Recent Developments/Updates
Table 82. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. CureVac Basic Information, Area Served and Competitors
Table 84. CureVac Major Business
Table 85. CureVac Small Nucleic Acid Drug Product and Services
Table 86. CureVac Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. CureVac Recent Developments/Updates
Table 88. CureVac Competitive Strengths & Weaknesses
Table 89. Regulus Therapeutics Basic Information, Area Served and Competitors
Table 90. Regulus Therapeutics Major Business
Table 91. Regulus Therapeutics Small Nucleic Acid Drug Product and Services
Table 92. Regulus Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Regulus Therapeutics Recent Developments/Updates
Table 94. Regulus Therapeutics Competitive Strengths & Weaknesses
Table 95. ProQR Basic Information, Area Served and Competitors
Table 96. ProQR Major Business
Table 97. ProQR Small Nucleic Acid Drug Product and Services
Table 98. ProQR Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. ProQR Recent Developments/Updates
Table 100. ProQR Competitive Strengths & Weaknesses
Table 101. Secarna Basic Information, Area Served and Competitors
Table 102. Secarna Major Business
Table 103. Secarna Small Nucleic Acid Drug Product and Services
Table 104. Secarna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Secarna Recent Developments/Updates
Table 106. Secarna Competitive Strengths & Weaknesses
Table 107. MiNA Therapeutics Basic Information, Area Served and Competitors
Table 108. MiNA Therapeutics Major Business
Table 109. MiNA Therapeutics Small Nucleic Acid Drug Product and Services
Table 110. MiNA Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. MiNA Therapeutics Recent Developments/Updates
Table 112. MiNA Therapeutics Competitive Strengths & Weaknesses
Table 113. Sylentis Basic Information, Area Served and Competitors
Table 114. Sylentis Major Business
Table 115. Sylentis Small Nucleic Acid Drug Product and Services
Table 116. Sylentis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Sylentis Recent Developments/Updates
Table 118. Sylentis Competitive Strengths & Weaknesses
Table 119. Arrowhead Basic Information, Area Served and Competitors
Table 120. Arrowhead Major Business
Table 121. Arrowhead Small Nucleic Acid Drug Product and Services
Table 122. Arrowhead Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Arrowhead Recent Developments/Updates
Table 124. Arrowhead Competitive Strengths & Weaknesses
Table 125. Silence Therapeutics Basic Information, Area Served and Competitors
Table 126. Silence Therapeutics Major Business
Table 127. Silence Therapeutics Small Nucleic Acid Drug Product and Services
Table 128. Silence Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Silence Therapeutics Recent Developments/Updates
Table 130. Dicerna Basic Information, Area Served and Competitors
Table 131. Dicerna Major Business
Table 132. Dicerna Small Nucleic Acid Drug Product and Services
Table 133. Dicerna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Small Nucleic Acid Drug Upstream (Raw Materials)
Table 135. Small Nucleic Acid Drug Typical Customers
LIST OF FIGURE
Figure 1. Small Nucleic Acid Drug Picture
Figure 2. World Small Nucleic Acid Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Small Nucleic Acid Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Small Nucleic Acid Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Small Nucleic Acid Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Small Nucleic Acid Drug Revenue (2018-2029) & (USD Million)
Figure 13. Small Nucleic Acid Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Small Nucleic Acid Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Small Nucleic Acid Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Small Nucleic Acid Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Small Nucleic Acid Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Small Nucleic Acid Drug Markets in 2022
Figure 27. United States VS China: Small Nucleic Acid Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Small Nucleic Acid Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Small Nucleic Acid Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Small Nucleic Acid Drug Market Size Market Share by Type in 2022
Figure 31. Antisense Oligonucleotides (ASO)
Figure 32. siRNA
Figure 33. Other
Figure 34. World Small Nucleic Acid Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Small Nucleic Acid Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Small Nucleic Acid Drug Market Size Market Share by Application in 2022
Figure 37. Neuromuscular Diseases
Figure 38. hATTR
Figure 39. Other
Figure 40. Small Nucleic Acid Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
